BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19843035)

  • 1. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression.
    Pinsky BW; Takemoto SK; Lentine KL; Burroughs TE; Schnitzler MA; Salvalaggio PR
    Am J Transplant; 2009 Nov; 9(11):2597-606. PubMed ID: 19843035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients.
    Takemoto SK; Pinsky BW; Schnitzler MA; Lentine KL; Willoughby LM; Burroughs TE; Bunnapradist S
    Am J Transplant; 2007 Dec; 7(12):2704-11. PubMed ID: 17868065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence in patients in the first year after kidney transplantation and its impact on graft loss and mortality: a cross-sectional and prospective study.
    Prihodova L; Nagyova I; Rosenberger J; Majernikova M; Roland R; Groothoff JW; van Dijk JP
    J Adv Nurs; 2014 Dec; 70(12):2871-83. PubMed ID: 24853863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients.
    Chisholm-Burns MA; Spivey CA; Rehfeld R; Zawaideh M; Roe DJ; Gruessner R
    Am J Transplant; 2009 Nov; 9(11):2497-504. PubMed ID: 19681814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK.
    Muduma G; Odeyemi I; Pollock RF
    J Med Econ; 2015; 18(12):1050-9. PubMed ID: 26201252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction Therapy, Rejection, and Graft Outcomes in Pediatric and Adolescent Kidney Transplant Recipients.
    Mincham CM; Wong G; Teixeira-Pinto A; Kennedy S; Alexander S; Larkins N; Lim WH
    Transplantation; 2017 Sep; 101(9):2146-2151. PubMed ID: 28832451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.
    Lazzaro C; McKechnie T; McKenna M
    J Nephrol; 2002; 15(5):580-8. PubMed ID: 12455727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model approach.
    Jürgensen JS; Arns W; Hass B
    Eur J Health Econ; 2010 Feb; 11(1):15-25. PubMed ID: 19296139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting acute rejection in children, adolescents, and young adults with a kidney transplant by assessing barriers to taking medication.
    Varnell CD; Rich KL; Zhang B; Carle AC; Pai ALH; Modi AC; Hooper DK
    Pediatr Nephrol; 2021 Aug; 36(8):2453-2461. PubMed ID: 33501558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
    Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
    Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipients.
    Spivey CA; Chisholm-Burns MA; Damadzadeh B; Billheimer D
    Clin Transplant; 2014 Jan; 28(1):96-104. PubMed ID: 24329814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Income-related disparities in kidney transplant graft failures are eliminated by Medicare's immunosuppression coverage.
    Woodward RS; Page TF; Soares R; Schnitzler MA; Lentine KL; Brennan DC
    Am J Transplant; 2008 Dec; 8(12):2636-46. PubMed ID: 19032227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
    Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
    Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival.
    Younas N; Wu CM; Shapiro R; McCauley J; Johnston J; Tan H; Basu A; Schaefer H; Smetanka C; Winkelmayer WC; Unruh M
    BMC Nephrol; 2010 Apr; 11():5. PubMed ID: 20359353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction type and outcomes for kidney graft and patient survival in recipients with prior lung transplantation in the United States.
    Riad S; Goswami U; Jackson S; Hertz M; Matas A
    J Heart Lung Transplant; 2020 Feb; 39(2):157-164. PubMed ID: 31837899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal assessment of adherence with immunosuppressive therapy following kidney transplantation from the Mycophenolic Acid Observational REnal Transplant (MORE) study.
    Tsapepas D; Langone A; Chan L; Wiland A; McCague K; Chisholm-Burns M
    Ann Transplant; 2014 Apr; 19():174-81. PubMed ID: 24743224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allograft and Patient Outcomes Between Indigenous and Nonindigenous Kidney Transplant Recipients.
    Howson P; Irish AB; D'Orsogna L; Chakera A; Swaminathan R; Perry G; De Santis D; Tolentino R; Wong G; Lim WH
    Transplantation; 2020 Apr; 104(4):847-855. PubMed ID: 32224814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C.
    Luan FL; Schaubel DE; Zhang H; Jia X; Pelletier SJ; Port FK; Magee JC; Sung RS
    Transplantation; 2008 Jun; 85(11):1601-6. PubMed ID: 18551066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation.
    Snowsill TM; Moore J; Mujica Mota RE; Peters JL; Jones-Hughes TL; Huxley NJ; Coelho HF; Haasova M; Cooper C; Lowe JA; Varley-Campbell JL; Crathorne L; Allwood MJ; Anderson R
    Nephrol Dial Transplant; 2017 Jul; 32(7):1251-1259. PubMed ID: 28873970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and sex determine conversion from immediate-release to extended-release tacrolimus in a multi-center cohort of Canadian pediatric renal transplant recipients.
    Lang S; Sharma A; Foster B; Gibson IW; Ho J; Nickerson P; Wishart D; Blydt-Hansen T
    Pediatr Transplant; 2021 Aug; 25(5):e13959. PubMed ID: 33368914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.